Report

Negative Regulation of Toll-Like Receptor Signaling by NF-κB p50 Ubiquitination Blockade

Science  03 Aug 2007:
Vol. 317, Issue 5838, pp. 675-678
DOI: 10.1126/science.1142953

You are currently viewing the abstract.

View Full Text

Abstract

Toll-like receptors (TLRs) trigger the production of inflammatory cytokines and shape adaptive and innate immunity to pathogens. We report the identification of B cell leukemia (Bcl)–3 as an essential negative regulator of TLR signaling. By blocking ubiquitination of p50, a member of the nuclear factor (NF)-κB family, Bcl-3 stabilizes a p50 complex that inhibits gene transcription. As a consequence, Bcl-3–deficient mice and cells were found to be hypersensitive to TLR activation and unable to control responses to lipopolysaccharides. Thus, p50 ubiquitination blockade by Bcl-3 limits the strength of TLR responses and maintains innate immune homeostasis. These findings indicate that the p50 ubiquitination pathway can be selectively targeted to control deleterious inflammatory diseases.

View Full Text

Related Content